These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3942959)

  • 1. A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers.
    McDivitt RW; Stone KR; Craig RB; Palmer JO; Meyer JS; Bauer WC
    Cancer; 1986 Jan; 57(2):269-76. PubMed ID: 3942959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical breast carcinoma cell kinetics: review and update.
    Meyer JS; McDivitt RW; Stone KR; Prey MU; Bauer WC
    Breast Cancer Res Treat; 1984; 4(2):79-88. PubMed ID: 6378283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
    Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
    Int J Cancer; 1992 Apr; 51(1):28-33. PubMed ID: 1563841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling.
    McDivitt RW; Stone KR; Craig RB; Meyer JS
    Lab Invest; 1985 Mar; 52(3):287-91. PubMed ID: 2983150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group.
    Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
    Acta Oncol; 1992; 31(3):283-92. PubMed ID: 1622647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.
    Kute TE; Muss HB; Hopkins M; Marshall R; Case D; Kammire L
    Breast Cancer Res Treat; 1985; 6(2):113-21. PubMed ID: 4052638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
    Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF
    Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.
    Leers MP; Schutte B; Theunissen PH; Ramaekers FC; Nap M
    Hum Pathol; 2000 May; 31(5):584-92. PubMed ID: 10836298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy.
    Meyer JS; Wittliff JL
    Int J Cancer; 1991 Jan; 47(2):213-20. PubMed ID: 1988366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer.
    Wingren S; Stål O; Sullivan S; Brisfors A; Nordenskjöld B
    Int J Cancer; 1994 Oct; 59(1):7-10. PubMed ID: 7523314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.
    Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Lehtinen M; Koivula T
    Cancer; 1988 Nov; 62(10):2183-90. PubMed ID: 3179930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
    Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
    Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
    Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
    Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.